Description

Ethyl 3-[(4-Bromophenyl)(Hydroxy)Methyl]Isoxazole-4-Carboxylate is a high-purity, advanced pharmaceutical intermediate featuring a unique isoxazole core functionalized with bromophenyl and hydroxymethyl groups. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel bioactive molecules. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers for developing new therapeutic agents, including potential kinase inhibitors and anti-inflammatory drugs.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, especially those targeting specific enzyme pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new therapeutic targets.
• Active Pharmaceutical Ingredient (API) Development: Serves as a precursor in the multi-step synthesis of complex active molecules.
• Biochemical Probe Synthesis: Utilized to create specialized probes for studying biological mechanisms and protein interactions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations engaged in custom synthesis and process development for clients.
• Academic Research: Employed in university and institutional labs for exploratory synthetic chemistry and pharmacology projects.

Basic Information

Product Name	Ethyl 3-[(4-Bromophenyl)(Hydroxy)Methyl]Isoxazole-4-Carboxylate
CAS No.	2006277-63-8
Molecular Formula	C13H12BrNO4
Molecular Weight	326.14 g/mol
Synonyms	Ethyl 3-[(4-bromophenyl)(hydroxy)methyl]-4-isoxazolecarboxylate; 4-Isoxazolecarboxylic acid, 3-[(4-bromophenyl)hydroxymethyl]-, ethyl ester; Ethyl 3-((4-bromophenyl)(hydroxy)methyl)isoxazole-4-carboxylate; 2006277-63-8; AI3-73962; SCHEMBL24848027; ZINC000253899793; AKOS040750623
EINECS	Contact for details

Quality Control

Our Ethyl 3-[(4-Bromophenyl)(Hydroxy)Methyl]Isoxazole-4-Carboxylate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and NMR for structural confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting identity, purity, and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.